Displaying drugs 14576 - 14600 of 14829 in total
Pridopidine
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational
Oxomemazine
Experimental
Tin protoporphyrin IX
Investigational
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
Methyl isocyanate
Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.
Investigational
9-Deazahypoxanthine
Experimental
Isatoic anhydride
Experimental
3-Aza-2,3-Dihydrogeranyl Diphosphate
Experimental
2-Methyl-3-(2-Aminothiazolo)Propanal
Experimental
2-Dimethylamino-Ethyl-Diphosphate
Experimental
Desidustat
Desidustat is under investigation in clinical trial NCT04012957 (Desidustat in the Treatment of Anemia in CKD).
Investigational
Atl146e
ATL146e is an anti-inflammatory compounds which is an agonist of A2A adenosine receptors.
Investigational
R1204
R1204 is G-protein-coupled receptor modulator. It is developed for the treatment of depression.
Investigational
AP5280
AP5280 is a novel N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-bound platinum (Pt) therapeutic designed to increase the therapeutic index relative to conventional, small-molecule platinum agents.
Investigational
Quinalizarin
Experimental
2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE
Experimental
Tiletamine
This drug is a dissociative anesthetic agent that falls under the drug category of NMDA receptor antagonists. Tiletamine is chemically similar to another dissociative anesthetic, ketamine. Tiletamine hydrochloride, the salt form, exists as odorless white crystals.
Vet approved
N-Formylpiperidine
Experimental
Thiocoumarin
Experimental
Displaying drugs 14576 - 14600 of 14829 in total